<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02319343</url>
  </required_header>
  <id_info>
    <org_study_id>HK_VL_08_2014</org_study_id>
    <nct_id>NCT02319343</nct_id>
  </id_info>
  <brief_title>Effect of Methylprednisolone on Quadriceps Muscle Function in Patients Undergoing Total Knee-arthroplasty</brief_title>
  <official_title>Effect of Preoperative Intravenous High Dose Methylprednisolone on Quadriceps Muscle Function in Patients Scheduled for Total Knee-arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the pathophysiological effects of a single dose Methylprednisolone
      administered prior to total knee-arthroplasty (TKA). The investigators examine the effect on
      thigh muscle function to evaluate the efficacy of Methylprednisolone on knee-extension
      strength at discharge after TKA.

      Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will
      receive placebo.

      The investigators hypothesize that the group receiving Methylprednisolone will experience
      smaller loss of knee-extension strength compared to the placebo-group, early after TKA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The anti-inflammatory effects of glucocorticoids are well known. The beneficial effects in
      postoperative pain, postoperative nausea and vomiting are well-documented.

      Knee-arthroplasty surgery and the inflammatory stress response in general affect the
      potential of recovery. The quadriceps muscle strength is shown to be reduced significantly
      (80%) early after surgery. The mechanism is thought related to inhibitory reflexes and pain
      caused by surgical induced inflammation around the knee joint. The effect of glucocorticoids
      on the quadriceps muscle function after knee-arthroplasty surgery is unknown and calls for
      further investigation.

      The study is to be considered as explorative.

      The primary analysis of the primary outcome measure is a comparison of the changes in knee
      extension strength from baseline to 48 hours postoperatively between the two groups.

      For calculation of sample size the average loss of strength from baseline (before surgery) to
      48 hours after TKA-surgery being 0.8 Nm/kg body weight (SD=0.39, Holm et al. 2010), a risk of
      type I errors 5% and a risk of type II errors 20% (80% power) were used. The sample size is
      estimated to reveal a group difference in knee extension strength of minimum 40%.

      The primary analysis is carried out on all included patients (intention-to-treat) with
      baseline values as covariate. Secondary exploratory per-protocol analysis might be performed.
      Missing outcomes will be analysed using multiple imputation due to expected strong time
      trends.

      The secondary outcome measures; a group difference of 6 sec. (Timed Up &amp; Go) and 2 cm (knee
      circumference) are considered clinically relevant. The statistical power is based on the
      calculation outlined above using the same test prerequisites.

      For further details please also view the European Clinical Trials Database (EudraCT)
      registration:

      EudraCT nr.: 2014-003395-23
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in isometric knee extension strength measured as Nm/kg from baseline to 48 hours after surgery</measure>
    <time_frame>two days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Timed Up &amp; Go (sec.) from baseline (before surgery) to 48 hours after surgery</measure>
    <time_frame>two days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in knee circumference (cm) from baseline (before surgery) to 48 hours after surgery</measure>
    <time_frame>two days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain intensity from baseline (before surgery) to 48 hours after surgery</measure>
    <time_frame>two days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in concentration of C-reactive Protein from baseline (before surgery) to 48 hours after surgery</measure>
    <time_frame>two days after suregry</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Osteoarthrosis</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative single high dose of Solu-Medrol 125 mg iv.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic Sodium Chloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Preoperative single dose of isotonic Sodium Chloride.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Comparison of preoperative single high dose of Methylprednisolone 125 mg iv. and isotonic Sodium Chloride (placebo)</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <other_name>Solu-Medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic Sodium Chloride</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Isotonic Sodium Chloride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthrosis

          -  Undergoing total unilateral knee-arthroplasty surgery

          -  Speak and understand Danish

          -  Have given informed consent

        Exclusion Criteria:

          -  Revision, bilateral or uni chamber knee-arthroplasty surgery

          -  General anaesthesia

          -  Allergy or intolerance towards Methylprednisolone

          -  Local or systemic infection

          -  Permanent systemic treatment with steroids within 30 days preoperatively

          -  Insulin-dependent diabetes

          -  Active treatment of ulcer within 3 months preoperatively

          -  Cancer disease

          -  Autoimmune disease incl. rheumatoid arthritis

          -  Pregnant or breast feeding women

          -  Menopause &lt;1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viktoria Lindberg-Larsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section for Surgical Pathophysiology, Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Husted H. Fast-track hip and knee arthroplasty: clinical and organizational aspects. Acta Orthop Suppl. 2012 Oct;83(346):1-39. doi: 10.3109/17453674.2012.700593. Review.</citation>
    <PMID>23205862</PMID>
  </reference>
  <reference>
    <citation>Kehlet H. Fast-track hip and knee arthroplasty. Lancet. 2013 May 11;381(9878):1600-2. doi: 10.1016/S0140-6736(13)61003-X.</citation>
    <PMID>23663938</PMID>
  </reference>
  <reference>
    <citation>Khan SK, Malviya A, Muller SD, Carluke I, Partington PF, Emmerson KP, Reed MR. Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop. 2014 Feb;85(1):26-31. doi: 10.3109/17453674.2013.874925. Epub 2013 Dec 20.</citation>
    <PMID>24359028</PMID>
  </reference>
  <reference>
    <citation>Malviya A, Martin K, Harper I, Muller SD, Emmerson KP, Partington PF, Reed MR. Enhanced recovery program for hip and knee replacement reduces death rate. Acta Orthop. 2011 Oct;82(5):577-81. doi: 10.3109/17453674.2011.618911. Epub 2011 Sep 6.</citation>
    <PMID>21895500</PMID>
  </reference>
  <reference>
    <citation>Lunn TH, Kristensen BB, Andersen LØ, Husted H, Otte KS, Gaarn-Larsen L, Kehlet H. Effect of high-dose preoperative methylprednisolone on pain and recovery after total knee arthroplasty: a randomized, placebo-controlled trial. Br J Anaesth. 2011 Feb;106(2):230-8. doi: 10.1093/bja/aeq333. Epub 2010 Dec 3.</citation>
    <PMID>21131371</PMID>
  </reference>
  <reference>
    <citation>Bandholm T, Kehlet H. Physiotherapy exercise after fast-track total hip and knee arthroplasty: time for reconsideration? Arch Phys Med Rehabil. 2012 Jul;93(7):1292-4. doi: 10.1016/j.apmr.2012.02.014. Epub 2012 Feb 27.</citation>
    <PMID>22494947</PMID>
  </reference>
  <reference>
    <citation>Geborek P, Månsson B, Wollheim FA, Moritz U. Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength. Rheumatol Int. 1990;9(6):265-70.</citation>
    <PMID>2315606</PMID>
  </reference>
  <reference>
    <citation>Rice DA, McNair PJ. Quadriceps arthrogenic muscle inhibition: neural mechanisms and treatment perspectives. Semin Arthritis Rheum. 2010 Dec;40(3):250-66. doi: 10.1016/j.semarthrit.2009.10.001. Epub 2009 Dec 2. Review.</citation>
    <PMID>19954822</PMID>
  </reference>
  <reference>
    <citation>Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002 Nov;195(5):694-712. Review.</citation>
    <PMID>12437261</PMID>
  </reference>
  <results_reference>
    <citation>Holm B, Kristensen MT, Bencke J, Husted H, Kehlet H, Bandholm T. Loss of knee-extension strength is related to knee swelling after total knee arthroplasty. Arch Phys Med Rehabil. 2010 Nov;91(11):1770-6. doi: 10.1016/j.apmr.2010.07.229.</citation>
    <PMID>21044725</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2014</study_first_submitted>
  <study_first_submitted_qc>December 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2014</study_first_posted>
  <last_update_submitted>April 7, 2016</last_update_submitted>
  <last_update_submitted_qc>April 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Viktoria Oline Lindberg-Larsen</investigator_full_name>
    <investigator_title>MD, research assistant</investigator_title>
  </responsible_party>
  <keyword>Glucocorticoid</keyword>
  <keyword>Quadriceps muscle function</keyword>
  <keyword>Knee arthroplasty, total</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

